Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

Detalles Bibliográficos
Autores principales: Greening, David W., Lee, Sze Ting, Ji, Hong, Simpson, Richard J., Rigopoulos, Angela, Murone, Carmel, Fang, Catherine, Gong, Sylvia, O'Keefe, Graeme, Scott, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085247/
https://www.ncbi.nlm.nih.gov/pubmed/27654651
http://dx.doi.org/10.18632/oncotarget.9855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085247/
https://www.ncbi.nlm.nih.gov/pubmed/27654651
http://dx.doi.org/10.18632/oncotarget.9855

Ejemplares similares